The Industry

September 2005
Pharmaceutical Representative;Sep2005, Vol. 35 Issue 9, p10
Presents news briefs pertaining to the pharmaceutical industry in the United States. Teva Pharmaceutical Industries Ltd.'s signing of a definitive agreement to acquire Miami, Florida-based Ivax Corp.; PDI Inc.'s signing of an agreement to copromote Irvine, California-based Allergan Inc.'s Zymar; BioMarin Pharmaceutical Inc.'s decision to lay-off salespeople responsible for promoting the corticosteroid Orapre. INSET: News Focus.


Related Articles

  • TEVA acquires IVAX.  // Drug Topics;8/8/2005, Vol. 149 Issue 15, p4 

    Reports on TEVA Pharmaceutical Industries Ltd.'s acquisition of IVAX Corp. in the United States.

  • Generics Watch.  // Drug Store News;1/17/2000, Vol. 22 Issue 1, p22 

    Presents news briefs on generic drugs in the United States (US) as of January 17, 2000. Launching of Teva's Diltiazem Extended Release Capsules for the treatment of hypertension and angina; Approval of the US Food and Drug Administration for IVAX Corp.'s ANDA for albuterol sulfate inhalation...

  • Watson Gains 15 Drugs in Teva's Acquisition of Barr. Reed, Vita // Orange County Business Journal;12/29/2008, Vol. 31 Issue 51, p28 

    The article offers information related to pharmaceutical industry in California in 2008. Watson Pharmaceuticals Inc. has gained the rights to some generic drugs as part of the settlement with Teva Pharmaceuticals Industries Ltd. and the Federal Trade Commission. Edwards Lifesciences Corp. has...

  • Competition Pains Drive Generic Drug Deals. Shearer, Brent // Mergers & Acquisitions: The Dealermaker's Journal;Oct2005, Vol. 40 Issue 10, p30 

    The article reports on the impact of the acquisition of IVAX Corp. by Teva Pharmaceutical Industries Ltd. on the pharmaceutical industry in the U.S. Teva also purchased Bayer's French generic business, Dorom SRL and Sicor Inc. Competition is one of the key factors that drive Teva's series of...

  • Generic drugs: Ivax purchase puts Teva back on top.  // PharmaWatch: Monthly Review;Sep2005, Vol. 4 Issue 9, p33 

    Reports that Teva Pharmaceutical Industries Ltd. has agreed to acquire rival generics maker Ivax Corp. for $7.4 billion. Information on the benefits of the deal for Teva; Effect of the company's growth on Novartis AG's drug Sandoz; Forecasts for the generic drug market.

  • Teva regains top position in Ivax deal. Jarvis, Lisa // Chemical Market Reporter;8/1/2005, Vol. 268 Issue 4, p6 

    Points out that with the proposed acquisition of Ivax Corp., Teva Pharmaceutical Industries Ltd. is poised to reign once again over the global generics market. Generics industry's second megamerger for 2005; Analysts positive on the transaction; Advantages of the transaction for Teva.

  • Teva Pharmaceuticals USA. Rankin, Ken // Drug Store News;8/18/97, Vol. 19 Issue 13, pCP16 

    Profiles Kulpsville, Pennsylvania-based generic drug company Teva Pharmaceutical Industries Ltd. Contact information; Financial performance; Company history; Business profile.

  • Teva markets some of top generics.  // Drug Store News;8/18/97, Vol. 19 Issue 13, pCP54 

    Reports on developments related to Teva Pharmaceutical Industries Ltd. Drugs marketed; Business operations in the United States; Company profile.

  • Focusing on new products, partnering.  // Drug Store News;2/16/98, Vol. 20 Issue 3, pCP12 

    Profiles Sellersville, Pennsylvania-based Teva Pharmaceuticals Industries Ltd. New product strategy by the company for 1998; Partnerships being planned by the company; Comment by Bill Fletcher, chief executive officer of the company.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics